Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.30
Bid: 2.16
Ask: 2.30
Change: -0.09 (-3.88%)
Spread: 0.14 (6.481%)
Open: 2.30
High: 2.30
Low: 2.30
Prev. Close: 2.32
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SABMiller exec buys a round

Tue, 24th Jan 2012 16:32

The Managing Director of SABMiller's African division bought a round of shares just one day before the drinks giant announced it has signed a definitive transaction agreement with Anadolu Group and Anadolu Efes.The agreement allows the firm to form a strategic alliance between the firm's divisions in Turkey, Russia, the Commonwealth of Independent States (CIS), Central Asia and the Middle East. The terms of the agreement, announced back in October, mean that SABMiller will now transfer its Russian and Ukranian beer divisions (valued at $1.9bn) to Anadolu Efes, the fifth-largest European brewer and the world's sixth-largest Coca-Cola bottler. In return, SABMiller will hold a 24% equity stake in Andolu Efes. Mark Bowman, 45, purchased 963 shares at 2,382.845p each. Just a few days ago the brewer reported that its financial performance for the final quarter of 2011 had been in line with expectations. However, the European and North American divisions were noticeably weak, with larger volumes in Europe falling 2% while in the US sales were down 3.3%. Top Director BuysImmupharma (IMM) Director name: Mr Ajay AgrawalAmount purchased: 62,169 @ 80.00p Value: £49,735Immupharma (IMM) Director name: Dr Franco Di MuzioAmount purchased: 60,950 @ 81.00p Value: £49,370Stobart Group Ltd. (STOB) Director name: Mr Jesper KjaedegaardAmount purchased: 22,000 @ 122.80p Value: £27,016Mission Marketing Group (TMMG) Director name: Mr Dylan BoggAmount purchased: 100,000 @ 15.12p Value: £15,120Mediterranean Oil & Gas (MOG) Director name: Mr Miles DonnellyAmount purchased: 225,000 @ 5.30p Value: £11,925NR
More News
29 Sep 2020 18:19

IN BRIEF: Immupharma Raises Stake In Incanthera To 15.4%

IN BRIEF: Immupharma Raises Stake In Incanthera To 15.4%

Read more
22 Sep 2020 21:17

IN BRIEF: Immupharma Repays Lind Global Convertible Security

IN BRIEF: Immupharma Repays Lind Global Convertible Security

Read more
11 Sep 2020 14:09

IN BRIEF: Immupharma Still Awaiting FDA Reply For Lupuzor Submission

IN BRIEF: Immupharma Still Awaiting FDA Reply For Lupuzor Submission

Read more
11 Sep 2020 12:17

ImmuPharma confirms continued FDA delays for Lupuzor

(Sharecast News) - Specialist drug discovery and development company ImmuPharma on its special protocol assessment (SPA) submission to the US Food and Drug Administration (FDA) for the phase 3 trial of 'Lupuzor' in lupus patients.

Read more
2 Sep 2020 11:18

Immupharma Raises GBP6.5 Million In Oversubscribed Placing

Immupharma Raises GBP6.5 Million In Oversubscribed Placing

Read more
2 Sep 2020 09:25

Immupharma raises £6.5m in oversubscribed placing

(Sharecast News) - Drug discovery and development firm Immupharma has raised £6.5m, before fees, via an oversubscribed placing of 59.09m ordinary shares.

Read more
27 Jul 2020 17:50

IN BRIEF: ImmuPharma Partner Avion Submits Request To FDA For Lupuzor

IN BRIEF: ImmuPharma Partner Avion Submits Request To FDA For Lupuzor

Read more
27 Jul 2020 15:15

ImmuPharma clears 'important' regulatory hurdle for Lupuzor trial

(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced what it called "an important regulatory milestone" on Monday, in preparation for the new optimised international phase 3 trial of 'Lupuzor' for the autoimmune disease systemic lupus erythematosus.

Read more
11 Jun 2020 16:17

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
11 Jun 2020 13:53

Immupharma Gets Over USD6 Million Investment From US Healthcare Funds

Immupharma Gets Over USD6 Million Investment From US Healthcare Funds

Read more
14 May 2020 17:13

UK TRADING UPDATE SUMMARY: Byotrol Sees Continuation Of Strong Demand

UK TRADING UPDATE SUMMARY: Byotrol Sees Continuation Of Strong Demand

Read more
1 May 2020 09:51

ImmuPharma Annual Loss Narrows; Plans "Optimised" Lupuzor Trial

ImmuPharma Annual Loss Narrows; Plans "Optimised" Lupuzor Trial

Read more
31 Mar 2020 07:31

ImmuPharma Raises GBP1.5 Million Through Share Issue To Fund Expansion

ImmuPharma Raises GBP1.5 Million Through Share Issue To Fund Expansion

Read more
30 Mar 2020 16:18

ImmuPharma raises ?1.5m to fund development programmes

(Sharecast News) - Drug discovery and development company ImmuPharma announced subscriptions to raise ?1.5m through the issue of 15 million new ordinary shares at a price of 10p each on Monday.

Read more
28 Feb 2020 12:06

Immupharma Inks Subscription Agreement Amid Incanthera's NEX Float

Immupharma Inks Subscription Agreement Amid Incanthera's NEX Float

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.